EDAP vs. AXGN, SMLR, ZYXI, ELMD, OM, FONR, VANI, IRIX, RMTI, and ECOR
Should you be buying Edap Tms stock or one of its competitors? The main competitors of Edap Tms include AxoGen (AXGN), Semler Scientific (SMLR), Zynex (ZYXI), Electromed (ELMD), Outset Medical (OM), FONAR (FONR), Vivani Medical (VANI), IRIDEX (IRIX), Rockwell Medical (RMTI), and electroCore (ECOR).
AxoGen (NASDAQ:AXGN) and Edap Tms (NASDAQ:EDAP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.
AxoGen has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Edap Tms has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.
AxoGen presently has a consensus target price of $10.67, indicating a potential upside of 60.88%. Edap Tms has a consensus target price of $14.67, indicating a potential upside of 101.47%. Given AxoGen's higher possible upside, analysts plainly believe Edap Tms is more favorable than AxoGen.
AxoGen has a net margin of -13.66% compared to AxoGen's net margin of -35.03%. Edap Tms' return on equity of -22.38% beat AxoGen's return on equity.
AxoGen received 101 more outperform votes than Edap Tms when rated by MarketBeat users. Likewise, 72.59% of users gave AxoGen an outperform vote while only 62.89% of users gave Edap Tms an outperform vote.
80.3% of AxoGen shares are held by institutional investors. Comparatively, 62.7% of Edap Tms shares are held by institutional investors. 7.2% of AxoGen shares are held by company insiders. Comparatively, 0.2% of Edap Tms shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, Edap Tms had 4 more articles in the media than AxoGen. MarketBeat recorded 5 mentions for Edap Tms and 1 mentions for AxoGen. AxoGen's average media sentiment score of 0.52 beat Edap Tms' score of 0.00 indicating that Edap Tms is being referred to more favorably in the news media.
AxoGen has higher revenue and earnings than Edap Tms. AxoGen is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.
Summary
AxoGen beats Edap Tms on 12 of the 17 factors compared between the two stocks.
Get Edap Tms News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Edap Tms Competitors List
Related Companies and Tools